On January 9, 2017, the 16th participant was enrolled at the Charleston, South Carolina study site of our ongoing Phase 1study of the psychological effects of MDMAwhen used in a therapeutic setting by …
On November 30, 2016, the fourth participant was enrolled at the recently initiated Boulder, Colorado study site in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic …
On September 28, 2016, the 14th participant was enrolled in our ongoing Phase 1 study of the psychological effects of MDMA when taken in a therapeutic setting by healthy volunteers in Charleston, South …
On September 28, 2016, the 15th participant was enrolled at our study site in Charleston, South Carolina in our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting …
On August 31, 2016, the formal site initiation meeting took place at the new Boulder, Colorado, site for our ongoing Phase 1 study of the psychological effects of MDMA when taken in a therapeutic setting …
On July 5, 2016, the 13th participant was enrolled in our ongoing Phase 1 study of the psychological effects of MDMA when taken in a therapeutic setting by healthy volunteers. Enrollment in this study …
From December 6-11, 2014, MAPS held a five-day training in Buckinghamshire, UK, for researchers who will be involved in upcoming clinical studies of the therapeutic use of MDMA. The training included 30 …
The increasing number and global reach of MAPS’ MDMA-assisted psychotherapy studies means that maintaining consistency of therapeutic approach across study sites is essential. In light of this challenge, …
Second MDMA/PTSD Therapist Training Program, Soliciting More Applicants From April 7 to 12, Michael Mithoefer, M.D., and Annie Mithoefer B.S.N. led an MDMA/PTSD therapist-training program with eight attendees …
Our Institutional Review Board (IRB) has approved our protocol designed as a Phase 1 study of the psychological effects of MDMA in healthy volunteers. To view all of the documents that have entailed the …
After our first therapist training protocol (cleared by the FDA as a Phase 1 study of MDMAs psychological effects on healthy subjects) was initially deferred by the institutional review board (IRB), we …
Next version MDMA/PTSD Treatment Manual to be edited by Sherry Falsetti, Ph.D. We are very pleased to have contracted Psychologist Sherry Falsetti, Ph.D. to edit MAPS MDMA/PTSD treatment manual and to …
